Invented by John Arrizza, Fresenius Medical Care Holdings Inc

The market for remote monitoring and control of treatment parameters on a medical device during a medical treatment has witnessed significant growth in recent years. This technology has revolutionized the healthcare industry by allowing healthcare professionals to remotely monitor and control treatment parameters, enhancing patient care and improving treatment outcomes. Remote monitoring and control of treatment parameters involve the use of advanced medical devices equipped with sensors and communication capabilities. These devices can be connected to a network, enabling healthcare professionals to access real-time data and make necessary adjustments to treatment parameters from a remote location. This technology has proven to be particularly beneficial in situations where continuous monitoring and control are required, such as during surgeries or critical care treatments. One of the key drivers of the market for remote monitoring and control of treatment parameters is the increasing demand for personalized medicine. With advancements in medical technology, healthcare providers are now able to tailor treatment plans to individual patients based on their specific needs and conditions. Remote monitoring and control of treatment parameters play a crucial role in this process by allowing healthcare professionals to closely monitor patients’ responses to treatment and make necessary adjustments in real-time. Another factor contributing to the growth of this market is the rising prevalence of chronic diseases. Chronic diseases require long-term management and monitoring, often involving frequent visits to healthcare facilities. Remote monitoring and control of treatment parameters provide a convenient and cost-effective solution by allowing patients to receive continuous care from the comfort of their homes. This not only improves patient satisfaction but also reduces the burden on healthcare facilities. The COVID-19 pandemic has further accelerated the adoption of remote monitoring and control of treatment parameters. With the need for social distancing and minimizing in-person interactions, healthcare providers have increasingly turned to remote monitoring technologies to ensure the continuity of care. This has led to a surge in demand for remote monitoring devices and solutions, driving the growth of the market. However, despite the numerous benefits, there are certain challenges that need to be addressed for the wider adoption of remote monitoring and control of treatment parameters. One of the primary concerns is data security and privacy. As medical devices become more connected, there is an increased risk of data breaches and unauthorized access to sensitive patient information. Healthcare providers and device manufacturers need to invest in robust cybersecurity measures to ensure the protection of patient data. Furthermore, the cost of implementing remote monitoring and control systems can be a barrier to adoption, especially for smaller healthcare facilities or those in developing regions. The initial investment required for acquiring and integrating the necessary devices and infrastructure can be significant. However, as the technology continues to evolve and become more widespread, it is expected that the costs will decrease, making it more accessible to a broader range of healthcare providers. In conclusion, the market for remote monitoring and control of treatment parameters on a medical device during a medical treatment is experiencing rapid growth. This technology has the potential to transform healthcare delivery by enabling remote monitoring and adjustment of treatment parameters, leading to improved patient outcomes and personalized care. However, challenges such as data security and cost need to be addressed to ensure widespread adoption and maximize the benefits of this technology.

The Fresenius Medical Care Holdings Inc invention works as follows

A method for establishing a connection between a medical device that is a first and another medical device using a short range wireless technology protocol. The first medical devices receives connection information about the second device via the short range wireless technology protocol.

Background for Remote Monitoring and Control of Treatment Parameters on a Medical Device During a Medical Treatment

Renal failure or dysfunction, and in particular end-stage kidney disease, can cause the body to lose its ability to excrete harmful metabolites and remove water, as well as maintain an acid-base equilibrium and regulate electrolyte and minerals concentrations within physiological limits. The toxic uremic waste products, such as urea and creatinine, can accumulate in tissues, resulting in death for a patient if the kidney’s filtration function is not replaced.

Dialysis is used to replace the kidneys by removing waste products and excess water. In one type of dialysis treatment?hemodialysis?toxins are filtered from a patient’s blood externally in a hemodialysis machine. Dialyzers separate a large amount of dialysis solution externally supplied from a patient’s blood by a semipermeable membrane. The semi-permeable dialysis membrane allows wastes and toxins to be dialyzed out of blood.

Dialysis solutions and dialysates are typically composed of sodium chloride with other electrolytes such as potassium chloride or calcium chloride. They also contain a buffer, such a bicarbonate, or an acetate to create a physiological pH and an acid, which can be glucose or another osmotic substance.

In one aspect of a method, it includes the establishment of a wireless link between a medical device. The first medical device receives, via a protocol of short-range wireless technologies, the connection information relating to the second device in order to establish the wireless connection. The first medical device establishes a wireless link with the second device using the connection information.

Implementations can include any or all of the following features.

In some implementations the wireless connection may be established by using a different communication protocol than the protocol for short-range wireless technologies. The connection information specifies the information used by a communication protocol other that the short-range technology protocol.

In some implementations, a connection device may also receive, via the protocol of short-range wireless technologies, connection information relating to the second device. The method includes also providing the first medical devices with the connection information for the second device via the short-range technology protocol.

In some implementations the connection device can be a wand.

In some implementations the device used for connection is a mobile phone.

In some implementations, this method includes the second medical device receiving connection information from the first device via the short-range wireless technology protocol.

In some implementations, a method may also include sending, from the medical device 1, a request for establishing a wireless link with the second device.

In some implementations, a first and second medical devices are placed at a distance sufficient to allow them to communicate using the short-range wireless protocol.

In some implementations, a first medical instrument receives connection information from a second medical instrument as a result the first and second medical instruments making physical contact.

In some implementations, one or both of the first two medical devices include an accelerometer that is configured to detect physical contact.

In some implementations, a short-range wireless communication protocol is Near Field Communication (NFC). Each of the first and second medical devices includes a component that can communicate via NFC.

In some cases, the component may include an inductor.

In some implementations the wireless identifier is included in the connection information for the second medical device.

In some cases, the wireless identification is unique to each device.

In some implementations, a first medical device may be electrically isolated from a second medical device.

In some cases, the first device is a dialysis unit.

In some cases, the second device is an accessory that can be used to interact with dialysis machines.

Click here to view the patent on Google Patents.